CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):: US15870P3073
LEI:: 549300O8WKLP8QEG5U47
Country:: United States of America
Address:: 855 N. WOLFE STREET, 21205 BALTIMORE
Website:: https://championsoncology.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ORGANOIDSCIENCES LTD. Organoid-based platforms for drug testing and regenerative therapeutics.	South Korea	476040
Oricon Inc. Provides entertainment industry data, music charts, web media, and marketing services.	Japan	4800
ORIENTBIO Inc. Provides animal models & technical services for preclinical R&D to pharma & research institutions.	South Korea	002630
Oryzon Genomics S.A. Develops epigenetic-based medicines for cancer and central nervous system disorders.	Spain	ORY
OSCOTECInc. A clinical-stage drug discovery company developing innovative medicines for unmet needs.	South Korea	039200
OSE Immunotherapeutics Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.	France	OSE
Oxurion NV Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.	Belgium	OXUR
PA Co., Ltd Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.	Japan	4766
Passage BIO, Inc. Developing genetic medicines for severe CNS and neurodegenerative disorders.	United States of America	PASG
PCI Biotech Holding Biopharma firm evaluating its future after discontinuing its core technology development.	Norway	PCIB